Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041885-25-000008
Filing Date
2025-02-21
Accepted
2025-02-21 17:42:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5226
  Complete submission text file 0001041885-25-000008.txt   6915
Mailing Address 1325 AVENUE OF THE AMERICAS 18TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 18TH FLOOR NEW YORK NY 10019 2122697812
INGALLS & SNYDER LLC (Filed by) CIK: 0001041885 (see all company filings)

EIN.: 135156620 | State of Incorp.: NY | Fiscal Year End: 0930
Type: SCHEDULE 13G/A

Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Subject) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-85273 | Film No.: 25653434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)